首页 > 最新文献

Head and neck tumors (HNT)最新文献

英文 中文
Treatment strategies of recurrent jaw osteosarcoma: case report 复发性颌骨肉瘤的治疗策略:病例报告
Pub Date : 2023-12-11 DOI: 10.17650/2222-1468-2023-13-3-89-97
O. A. Saprina, M. Kropotov, B. B. Vyzhigina, K. А. Ganina
Osteosarcoma of jaw is a rare malignant neoplasm of the maxillofacial region. Morphologically and radiologically identical to trunk and extremities sarcomas, but clinical features and prognosis of the disease have important differences. The strategy in treatment of gnathic sarcomas extrapolated from peripheral sarcomas, and represents an integrated multidisciplinary approach. The role of neoadjuvant chemotherapy remains controversial as well as adjuvant chemotherapy due to lack of clinical research. Surgical treatment with achievement of clean resection margins is the main favorable prognostic factor. Fibular free flap has been widely used for the last decade for mandible reconstruction. The strategies of treatment recurrent disease directly depend on ability to perform complete resection. Despite increased technical complexity, secondary free peroneal flap reconstruction can be performed safely, reliably, and with similar results to the premier segmental mandibulectomy. The use of radiation therapy is limited to unresectable or recurrent lesions. Well known that jaw osteosarcomas have a relatively higher survival rate and low metastasis rate, however, local recurrences significantly worsen the prognosis of patients. The following is a clinical case of treatment recurrent jaw osteosarcoma using second fibular free flap.
颌骨骨肉瘤是一种罕见的颌面部恶性肿瘤。在形态学和放射学上与躯干和四肢肉瘤相同,但临床特征和预后却有很大不同。颌面部肉瘤的治疗策略借鉴了外周肉瘤的治疗方法,是一种多学科综合治疗方法。由于缺乏临床研究,新辅助化疗和辅助化疗的作用仍存在争议。手术治疗的主要有利预后因素是达到干净的切除边缘。近十年来,腓骨游离皮瓣被广泛用于下颌骨重建。复发疾病的治疗策略直接取决于能否进行完整切除。尽管技术复杂性增加,但二次游离腓骨瓣重建术可以安全、可靠地进行,其效果与主要的下颌骨节段切除术相似。放射治疗仅限于无法切除或复发的病灶。众所周知,颌骨骨肉瘤的存活率相对较高,转移率较低,但局部复发会明显恶化患者的预后。以下是一例使用第二腓骨游离皮瓣治疗复发性颌骨骨肉瘤的临床病例。
{"title":"Treatment strategies of recurrent jaw osteosarcoma: case report","authors":"O. A. Saprina, M. Kropotov, B. B. Vyzhigina, K. А. Ganina","doi":"10.17650/2222-1468-2023-13-3-89-97","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-3-89-97","url":null,"abstract":"Osteosarcoma of jaw is a rare malignant neoplasm of the maxillofacial region. Morphologically and radiologically identical to trunk and extremities sarcomas, but clinical features and prognosis of the disease have important differences. The strategy in treatment of gnathic sarcomas extrapolated from peripheral sarcomas, and represents an integrated multidisciplinary approach. The role of neoadjuvant chemotherapy remains controversial as well as adjuvant chemotherapy due to lack of clinical research. Surgical treatment with achievement of clean resection margins is the main favorable prognostic factor. Fibular free flap has been widely used for the last decade for mandible reconstruction. The strategies of treatment recurrent disease directly depend on ability to perform complete resection. Despite increased technical complexity, secondary free peroneal flap reconstruction can be performed safely, reliably, and with similar results to the premier segmental mandibulectomy. The use of radiation therapy is limited to unresectable or recurrent lesions. Well known that jaw osteosarcomas have a relatively higher survival rate and low metastasis rate, however, local recurrences significantly worsen the prognosis of patients. The following is a clinical case of treatment recurrent jaw osteosarcoma using second fibular free flap.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"29 S2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138980705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Problems of follicular thyroid carcinoma diagnostics 甲状腺滤泡癌的诊断问题
Pub Date : 2023-12-11 DOI: 10.17650/2222-1468-2023-13-3-10-23
S. Titov, S. A. Lukyanov, S. V. Sergiyko, Y. Veryaskina, T. E. Ilyina, E. S. Kozorezov, S. Vorobyov
Introduction. Follicular thyroid cancer is much less common than papillary cancer. Nevertheless, the main difficulties in preoperative diagnosis are associated with this morphological type. A fine needle aspiration biopsy is not able to distinguish a benign follicular adenoma from a follicular carcinoma, which forces surgeons to perform diagnostic resection of the thyroid gland in all patients with a cytological conclusion «follicular tumor».Aim. To search for microRNAs specific to follicular cancer by sequencing a new generation.Materials and methods. The data of patients with a preoperative cytological conclusion «follicular tumor» operated at the Chelyabinsk Center for Endocrine Surgery from 2021 to 2022 were analyzed. Histological preparations were reviewed twice by pathologists. Genome sequencing was performed in 8 histological samples of follicular cancer and 8 samples of follicular adenoma. The expression levels of the selected microRNAs were compared with 198 archived cytological samples of various types of thyroid tumors.Results. The risk of malignancy at the cytological conclusion «follicular tumor» was 25.4 % (error 74.6 %). Follicular cancer was first detected in 36 patients, the incidence was 0.68 new cases per 100 thousand population per year. The diagnosis of «follicular cancer» was confirmed by 3 morphologists in 8 (36.4 %) cases. Sequencing revealed the 5 most distinct microRNAs between follicular cancer and follicular adenoma: miR-625, miR-323a, let-7a, let-7c and miR-574. The level of errors in the differentiation of follicular adenoma and follicular cancer using the microRNAs we selected was 21 % (35 % with cross-validation).Conclusion. Molecular genetic research at the preoperative stage, aimed at differentiating follicular cancer and follicular adenoma, in comparison with cytological research has a greater, but insufficient accuracy for making a final clinical decision.
导言滤泡状甲状腺癌比乳头状甲状腺癌少见得多。然而,术前诊断的主要困难与这种形态类型有关。细针穿刺活检无法区分良性滤泡腺瘤和滤泡癌,这迫使外科医生对所有细胞学结论为 "滤泡性肿瘤 "的患者进行甲状腺诊断性切除。通过新一代测序寻找滤泡癌特异性微RNA。分析了 2021 年至 2022 年在车里雅宾斯克内分泌外科中心手术的术前细胞学结论为 "滤泡肿瘤 "的患者数据。病理学家对组织学制剂进行了两次审查。对 8 份滤泡癌组织学样本和 8 份滤泡腺瘤样本进行了基因组测序。所选 microRNAs 的表达水平与 198 份归档的各类甲状腺肿瘤细胞学样本进行了比较。细胞学结论为 "滤泡瘤 "的恶性肿瘤风险为 25.4%(误差为 74.6%)。首次发现滤泡癌的患者有 36 人,发病率为每年每 10 万人新增病例 0.68 例。有 8 例(36.4%)患者的 "滤泡癌 "诊断得到了 3 位形态学专家的确认。测序结果显示,滤泡癌和滤泡腺瘤之间存在 5 种最不同的 microRNA:miR-625、miR-323a、let-7a、let-7c 和 miR-574。利用我们选择的 microRNAs 区分卵泡腺瘤和卵泡癌的误差率为 21%(交叉验证为 35%)。与细胞学研究相比,术前阶段旨在区分滤泡癌和滤泡腺瘤的分子遗传学研究具有更高的准确性,但不足以做出最终的临床决定。
{"title":"Problems of follicular thyroid carcinoma diagnostics","authors":"S. Titov, S. A. Lukyanov, S. V. Sergiyko, Y. Veryaskina, T. E. Ilyina, E. S. Kozorezov, S. Vorobyov","doi":"10.17650/2222-1468-2023-13-3-10-23","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-3-10-23","url":null,"abstract":"Introduction. Follicular thyroid cancer is much less common than papillary cancer. Nevertheless, the main difficulties in preoperative diagnosis are associated with this morphological type. A fine needle aspiration biopsy is not able to distinguish a benign follicular adenoma from a follicular carcinoma, which forces surgeons to perform diagnostic resection of the thyroid gland in all patients with a cytological conclusion «follicular tumor».Aim. To search for microRNAs specific to follicular cancer by sequencing a new generation.Materials and methods. The data of patients with a preoperative cytological conclusion «follicular tumor» operated at the Chelyabinsk Center for Endocrine Surgery from 2021 to 2022 were analyzed. Histological preparations were reviewed twice by pathologists. Genome sequencing was performed in 8 histological samples of follicular cancer and 8 samples of follicular adenoma. The expression levels of the selected microRNAs were compared with 198 archived cytological samples of various types of thyroid tumors.Results. The risk of malignancy at the cytological conclusion «follicular tumor» was 25.4 % (error 74.6 %). Follicular cancer was first detected in 36 patients, the incidence was 0.68 new cases per 100 thousand population per year. The diagnosis of «follicular cancer» was confirmed by 3 morphologists in 8 (36.4 %) cases. Sequencing revealed the 5 most distinct microRNAs between follicular cancer and follicular adenoma: miR-625, miR-323a, let-7a, let-7c and miR-574. The level of errors in the differentiation of follicular adenoma and follicular cancer using the microRNAs we selected was 21 % (35 % with cross-validation).Conclusion. Molecular genetic research at the preoperative stage, aimed at differentiating follicular cancer and follicular adenoma, in comparison with cytological research has a greater, but insufficient accuracy for making a final clinical decision.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"144 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138981417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical experience of combined organ-preserving treatment of laryngopharyngeal cancer with spread to the cervical esophagus 对扩散至颈食管的喉咽癌进行联合器官保留治疗的临床经验
Pub Date : 2023-12-11 DOI: 10.17650/2222-1468-2023-13-3-82-88
V. A. Rozhnov, P. I. Spirin, V. Polkin, I. Gulidov, A. V. Dem’yanovich, A. D. Kaprin, S. A. Ivanov
Introduction. Laryngopharyngeal cancer accounts for about half of the total number of malignant neoplasms of ENT organs. Despite the availability of examination, in most patients tumors of this localization are detected at late stages, and the long-term results of treatment of locally advanced cancer of the larynx remain unsatisfactory.Clinical case. This article presents two clinical cases of combined organ-preserving treatment of laryngopharyngeal cancer with spread to the cervical esophagus. At the first stage, patients underwent organ-preserving surgical treatment with a reconstructive plastic component according to the methodology developed at the A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center of Radiology. Then a postoperative course of chemoradiotherapy was carried out.Conclusion. The use of combined organ-preserving techniques using displaced skin-muscle flaps in the treatment of locally advanced laryngopharyngeal cancer involving the cervical esophagus allows in some cases to avoid crippling surgery, preserve the larynx and achieve satisfactory functional results, which significantly improves the quality of life of patients.
导言。喉咽癌约占耳鼻喉器官恶性肿瘤总数的一半。尽管可以进行检查,但大多数患者在晚期才发现这种局部肿瘤,而且局部晚期喉癌的长期治疗效果仍不令人满意。本文介绍了两例合并食管颈部转移的喉咽癌保留器官治疗的临床病例。在第一阶段,患者根据 A.F. Tsyb 医学放射学研究中心--国家放射学医学研究中心分部--制定的方法,接受了带有整形重建部分的保留器官手术治疗。然后进行术后放化疗。使用移位皮肌瓣联合器官保留技术治疗涉及颈食管的局部晚期喉咽癌,在某些情况下可以避免残废手术,保留喉部并获得满意的功能效果,从而显著提高患者的生活质量。
{"title":"Clinical experience of combined organ-preserving treatment of laryngopharyngeal cancer with spread to the cervical esophagus","authors":"V. A. Rozhnov, P. I. Spirin, V. Polkin, I. Gulidov, A. V. Dem’yanovich, A. D. Kaprin, S. A. Ivanov","doi":"10.17650/2222-1468-2023-13-3-82-88","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-3-82-88","url":null,"abstract":"Introduction. Laryngopharyngeal cancer accounts for about half of the total number of malignant neoplasms of ENT organs. Despite the availability of examination, in most patients tumors of this localization are detected at late stages, and the long-term results of treatment of locally advanced cancer of the larynx remain unsatisfactory.Clinical case. This article presents two clinical cases of combined organ-preserving treatment of laryngopharyngeal cancer with spread to the cervical esophagus. At the first stage, patients underwent organ-preserving surgical treatment with a reconstructive plastic component according to the methodology developed at the A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Center of Radiology. Then a postoperative course of chemoradiotherapy was carried out.Conclusion. The use of combined organ-preserving techniques using displaced skin-muscle flaps in the treatment of locally advanced laryngopharyngeal cancer involving the cervical esophagus allows in some cases to avoid crippling surgery, preserve the larynx and achieve satisfactory functional results, which significantly improves the quality of life of patients.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"57 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138979178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress protection method for surgical treatment of patients with head and neck cancer 头颈癌患者手术治疗的应力保护方法
Pub Date : 2023-12-11 DOI: 10.17650/2222-1468-2023-13-3-24-31
D. N. Vasiliev, D. Kulbakin, E. Choynzonov, S. V. Avdeev, D. Y. Azovskaya, A. A. Lee, N. M. Khavkin
Introduction. The surgical stage of treatment is the most important component of the combined method of treatment in cancer patients. However, it is associated with the development of a number of complications caused by stress. In this regard, the modern concept of an anesthesiological manual should also be aimed at protecting the body from surgical stress, which requires the search and development of new gentle methods of anesthesia.Aim. To provide an overview of modern stress protection methods in anesthesia and consider the role of dalargin with carbohydrate loading as a component of stress protection in oncological surgery.Materials and methods. Using the electronic resources of the PubMed and eLibrary search engines, a literary review of 147 scientific papers over the past 30 years has been conducted, which contain an evidence-based experimental and clinical base on the use of dalargin in medical practice.Results. A systematic review of stress protection methods in anesthesiology is presented. The role of dalargin in anesthesiological practice during surgical treatment in cancer patients, including when performing delayed reconstructions, is shown.Conclusion. The use of dalargin in combination with carbohydrate loading in cancer patients is justified and requires further detailed study. The ability to stimulate endogenous opioid receptors and modulate pain perception, its organoprotective and anti-inflammatory properties, as well as a favorable safety profile make dalargin a valuable addition to the tools for anesthesia in oncology.
导 言手术治疗阶段是癌症患者综合治疗方法中最重要的组成部分。然而,这也与压力导致的一系列并发症的发生有关。因此,麻醉学手册的现代概念也应旨在保护人体免受手术应激,这就需要寻找和开发新的温和麻醉方法。概述现代麻醉中的应激保护方法,并考虑达拉金与碳水化合物负荷作为肿瘤手术中应激保护的组成部分的作用。利用 PubMed 和 eLibrary 搜索引擎的电子资源,对过去 30 年中的 147 篇科学论文进行了文献综述,其中包含在医疗实践中使用达拉金的循证实验和临床依据。对麻醉学中的应激保护方法进行了系统回顾。结论。结论:在癌症患者中结合碳水化合物负荷使用达拉金是合理的,需要进一步详细研究。达拉金能够刺激内源性阿片受体,调节痛觉,具有器官保护和抗炎特性,而且安全性能良好,因此是肿瘤学麻醉工具的重要补充。
{"title":"Stress protection method for surgical treatment of patients with head and neck cancer","authors":"D. N. Vasiliev, D. Kulbakin, E. Choynzonov, S. V. Avdeev, D. Y. Azovskaya, A. A. Lee, N. M. Khavkin","doi":"10.17650/2222-1468-2023-13-3-24-31","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-3-24-31","url":null,"abstract":"Introduction. The surgical stage of treatment is the most important component of the combined method of treatment in cancer patients. However, it is associated with the development of a number of complications caused by stress. In this regard, the modern concept of an anesthesiological manual should also be aimed at protecting the body from surgical stress, which requires the search and development of new gentle methods of anesthesia.Aim. To provide an overview of modern stress protection methods in anesthesia and consider the role of dalargin with carbohydrate loading as a component of stress protection in oncological surgery.Materials and methods. Using the electronic resources of the PubMed and eLibrary search engines, a literary review of 147 scientific papers over the past 30 years has been conducted, which contain an evidence-based experimental and clinical base on the use of dalargin in medical practice.Results. A systematic review of stress protection methods in anesthesiology is presented. The role of dalargin in anesthesiological practice during surgical treatment in cancer patients, including when performing delayed reconstructions, is shown.Conclusion. The use of dalargin in combination with carbohydrate loading in cancer patients is justified and requires further detailed study. The ability to stimulate endogenous opioid receptors and modulate pain perception, its organoprotective and anti-inflammatory properties, as well as a favorable safety profile make dalargin a valuable addition to the tools for anesthesia in oncology.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138981729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myeloid sarcoma of the larynx as manifestation of the terminal stage of myeloproliferative disease 喉髓样肉瘤是骨髓增生性疾病终末期的表现
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-110-115
A. L. Kozhanov, L. Kozhanov, A. Kovrigina, N. S. Chernotalova
A rare clinical observation of advanced myeloid sarcoma developed through blast transformation of post-polycythemia vera myelofibrosis as extramedullary manifestation of acute myeloid leukemia affecting larynx, laryngopharynx, trachea, soft tissues of the neck, pleura, and skeletal bones is presented.
通过真性红细胞增多症后骨髓纤维化的细胞转化而形成的晚期髓系肉瘤,作为急性髓系白血病的髓外表现,影响喉部、喉咽部、气管、颈部软组织、胸膜和骨骼。
{"title":"Myeloid sarcoma of the larynx as manifestation of the terminal stage of myeloproliferative disease","authors":"A. L. Kozhanov, L. Kozhanov, A. Kovrigina, N. S. Chernotalova","doi":"10.17650/2222-1468-2023-13-1-110-115","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-110-115","url":null,"abstract":"A rare clinical observation of advanced myeloid sarcoma developed through blast transformation of post-polycythemia vera myelofibrosis as extramedullary manifestation of acute myeloid leukemia affecting larynx, laryngopharynx, trachea, soft tissues of the neck, pleura, and skeletal bones is presented.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"84 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81455257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Problems in preparation of legally binding documents for oncological and palliative patients and their solutions 为肿瘤和姑息治疗患者准备具有法律约束力的文件的问题及其解决办法
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-75-80
P. Gabay, B. Kamolov
Introduction. Oncological and palliative patients undergo treatment causing adverse events including mental and cognitive disorders leading to their inability to express their wishes in the legal sense. This affects the possibility of preparation of documents on disposal of property: wills, donation or sale and purchase agreements, letters of authorization.Aim. To consider problems arising when an oncological or palliative patient decides to dispose of their property and to suggest solutions to these problems.Materials and methods. An analysis of the current normative legal acts and legal precedents in the Russian Federation in the context of property disposal by severely ill patients was performed. Clinical guidelines on treatment of chronic pain in oncological and palliative patients, as well as Russian and international approaches to this therapy were considered.Results. Legal solutions for the considered problem appear to lack effectiveness. Use of tafalgin in treatment of severely ill patients can decrease risks and ease the process of preparation of documents on property disposal. This medication is indicated for chronic pain syndrome and unlike other pharmaceuticals is not an opioid analgesic and does not have severe side effects. Administration of tafalgin allows patients to retain mental clarity and avoid the risk of physical and psychological addiction.Conclusion. It is necessary to continue the search for new therapeutic approaches to chronic pain treatment taking into account needs and special aspects of oncological and palliative patients which would allow them to preserve full legal competency and dispose of their property without legal risks.
介绍。肿瘤和姑息治疗患者接受的治疗会导致不良事件,包括精神和认知障碍,导致他们无法在法律意义上表达自己的愿望。这影响到准备处置财产文件的可能性:遗嘱、捐赠或买卖协议、授权书。目的。考虑肿瘤患者或姑息治疗患者决定处置其财产时出现的问题,并提出解决这些问题的建议。材料和方法。对俄罗斯联邦目前在重病患者财产处置方面的规范性法律行为和法律先例进行了分析。讨论了肿瘤和姑息治疗患者治疗慢性疼痛的临床指南,以及俄罗斯和国际上的治疗方法。对所考虑的问题的法律解决办法似乎缺乏效力。使用他法algin治疗重症患者可降低风险并简化财产处置文件的编制过程。这种药物适用于慢性疼痛综合征,与其他药物不同,它不是阿片类镇痛药,也没有严重的副作用。给予他法algin可使患者保持精神清醒,避免身体和心理成瘾的风险。考虑到肿瘤和姑息治疗患者的需求和特殊方面,有必要继续寻找新的治疗方法来治疗慢性疼痛,这将使他们能够保持完全的法律能力,并在没有法律风险的情况下处置他们的财产。
{"title":"Problems in preparation of legally binding documents for oncological and palliative patients and their solutions","authors":"P. Gabay, B. Kamolov","doi":"10.17650/2222-1468-2023-13-1-75-80","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-75-80","url":null,"abstract":"Introduction. Oncological and palliative patients undergo treatment causing adverse events including mental and cognitive disorders leading to their inability to express their wishes in the legal sense. This affects the possibility of preparation of documents on disposal of property: wills, donation or sale and purchase agreements, letters of authorization.Aim. To consider problems arising when an oncological or palliative patient decides to dispose of their property and to suggest solutions to these problems.Materials and methods. An analysis of the current normative legal acts and legal precedents in the Russian Federation in the context of property disposal by severely ill patients was performed. Clinical guidelines on treatment of chronic pain in oncological and palliative patients, as well as Russian and international approaches to this therapy were considered.Results. Legal solutions for the considered problem appear to lack effectiveness. Use of tafalgin in treatment of severely ill patients can decrease risks and ease the process of preparation of documents on property disposal. This medication is indicated for chronic pain syndrome and unlike other pharmaceuticals is not an opioid analgesic and does not have severe side effects. Administration of tafalgin allows patients to retain mental clarity and avoid the risk of physical and psychological addiction.Conclusion. It is necessary to continue the search for new therapeutic approaches to chronic pain treatment taking into account needs and special aspects of oncological and palliative patients which would allow them to preserve full legal competency and dispose of their property without legal risks.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"64 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76977765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma 完全外显子组测序在多形性胶质母细胞瘤患者靶向药物管理中的作用
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-51-58
A. Kaminskiy, N. P. Zverev, A. A. Lyakhovets, D. Naskhletashvili, M. A. Gairyan, A. A. Isaev, D. Khmelkova, I. Plaksa
Introduction. Glioblastoma is the most common primary malignant glial tumor of the brain in adult patients. Median overall survival for this pathology varies between 3 and 12 months, and only 5 % of patients live for more than 5 years. Current treatment methods allow to slightly increase lifespan of the patients with glioblastoma but not in all cases.Aim – to determine the utility of full exome sequencing of biopsy materials of patients with glioblastoma using expanded gene panel for prescription of new targeted therapy.Materials and methods. The study included 28 patients with glioblastoma multiforme. Foundation One CDx assay was performed using DNA extraction from a paraffin block and next-generation sequencing. In total, 4 classes of genomic changes in 324 genes, introns of 34 genes taking part in rearrangements, as well as microsatellite instability and tumor mutation load were evaluated. For every tumor profile, individual therapy options were identified in accordance with the current knowledge, references for the relevant scientific studies were included. From some patients, feedback was received allowing to evaluate the dynamics of their condition and changes in therapy after the performed study.Results. Genes in which mutations are the most common were identified: EGFR – in 11 patients, CDKN2A – in 13, TP53 – in 9, TERT (frequent mutations in TERT gene promoters с.-124C>T and c.-146C>T) – in 15, MTAP – in 10. Mean mutation level was 4.5 mutations/ MB and tumors did not have microsatellite instability. For 6 patients, appropriate targeted therapy was identified.Conclusion. Sequencing using an extended gene panel is justified and recommended for patients with glioblastoma multiforme for selection of new targeted therapy.
介绍。胶质母细胞瘤是成人患者中最常见的原发性脑恶性胶质肿瘤。这种病理的中位总生存期在3到12个月之间,只有5%的患者存活超过5年。目前的治疗方法可以略微延长胶质母细胞瘤患者的寿命,但并非所有病例都如此。目的-确定利用扩展基因面板对胶质母细胞瘤患者活检材料进行全外显子组测序的效用,为新的靶向治疗处方提供依据。材料和方法。该研究包括28例多形性胶质母细胞瘤患者。使用石蜡块DNA提取和下一代测序进行Foundation One CDx检测。总共评估了324个基因的4类基因组变化,34个基因的内含子参与重排,以及微卫星不稳定性和肿瘤突变负荷。对于每一种肿瘤,根据现有知识确定个体治疗方案,并纳入相关科学研究的参考文献。从一些患者那里,我们收到了反馈,可以评估他们的病情动态以及在进行研究后治疗的变化。发现了最常见突变的基因:EGFR - 11例,CDKN2A - 13例,TP53 - 9例,TERT (TERT基因启动子频繁突变)6例。- 124c >T和c - 146c >t) - 15, MTAP - 10。平均突变水平为4.5个突变/ MB,肿瘤无微卫星不稳定性。对6例患者进行了合适的靶向治疗。使用扩展基因面板的测序是合理的,并推荐用于多形性胶质母细胞瘤患者选择新的靶向治疗。
{"title":"The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma","authors":"A. Kaminskiy, N. P. Zverev, A. A. Lyakhovets, D. Naskhletashvili, M. A. Gairyan, A. A. Isaev, D. Khmelkova, I. Plaksa","doi":"10.17650/2222-1468-2023-13-1-51-58","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-51-58","url":null,"abstract":"Introduction. Glioblastoma is the most common primary malignant glial tumor of the brain in adult patients. Median overall survival for this pathology varies between 3 and 12 months, and only 5 % of patients live for more than 5 years. Current treatment methods allow to slightly increase lifespan of the patients with glioblastoma but not in all cases.Aim – to determine the utility of full exome sequencing of biopsy materials of patients with glioblastoma using expanded gene panel for prescription of new targeted therapy.Materials and methods. The study included 28 patients with glioblastoma multiforme. Foundation One CDx assay was performed using DNA extraction from a paraffin block and next-generation sequencing. In total, 4 classes of genomic changes in 324 genes, introns of 34 genes taking part in rearrangements, as well as microsatellite instability and tumor mutation load were evaluated. For every tumor profile, individual therapy options were identified in accordance with the current knowledge, references for the relevant scientific studies were included. From some patients, feedback was received allowing to evaluate the dynamics of their condition and changes in therapy after the performed study.Results. Genes in which mutations are the most common were identified: EGFR – in 11 patients, CDKN2A – in 13, TP53 – in 9, TERT (frequent mutations in TERT gene promoters с.-124C>T and c.-146C>T) – in 15, MTAP – in 10. Mean mutation level was 4.5 mutations/ MB and tumors did not have microsatellite instability. For 6 patients, appropriate targeted therapy was identified.Conclusion. Sequencing using an extended gene panel is justified and recommended for patients with glioblastoma multiforme for selection of new targeted therapy.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80618539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The possibilities of ultrasound imaging in the diagnosis of follicular neoplasia of the thyroid gland 超声成像诊断甲状腺滤泡性肿瘤的可能性
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-81-90
D. Dolidze, Z. A. Bagatelia, A. Lukin, S. D. Сovantsev, T. V. Shevyakova, N. V. Pichugina, D. Skripnichenko, K. Mulaeva
Thyroid cancer is the most common cancer of the endocrine system. The diagnosis of thyroid cancer has taken a step forward due to the introduction of fine-needle biopsy of the thyroid gland with subsequent evaluation of cytological material using the Bethesda system. One category of this classification traditionally remains a gray area of diagnosis. The detection of a follicular tumor in the cytological material (category IV according to Bethesda) does not allow one to reliably classify the neoplasia as benign or malignant and requires surgical intervention. The traditional informative and widely used method for diagnosing thyroid tumors is ultrasound. However, the sensitivity and specificity of the method varies over a wide range. This review analyzes the literature on the possibilities of ultrasound diagnostics in assessing the malignant potential of follicular tumors of the thyroid gland.
甲状腺癌是内分泌系统最常见的癌症。由于引入了甲状腺细针活检,随后使用Bethesda系统对细胞学材料进行评估,甲状腺癌的诊断向前迈出了一步。这种分类的一个类别传统上仍然是诊断的灰色地带。在细胞学材料中检测滤泡性肿瘤(根据Bethesda分类为IV类)不能可靠地将肿瘤分类为良性或恶性,需要手术干预。传统的诊断甲状腺肿瘤的方法是超声。然而,该方法的灵敏度和特异性在很大范围内变化。本文综述了超声诊断在评估甲状腺滤泡性肿瘤恶性潜能方面的可能性。
{"title":"The possibilities of ultrasound imaging in the diagnosis of follicular neoplasia of the thyroid gland","authors":"D. Dolidze, Z. A. Bagatelia, A. Lukin, S. D. Сovantsev, T. V. Shevyakova, N. V. Pichugina, D. Skripnichenko, K. Mulaeva","doi":"10.17650/2222-1468-2023-13-1-81-90","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-81-90","url":null,"abstract":"Thyroid cancer is the most common cancer of the endocrine system. The diagnosis of thyroid cancer has taken a step forward due to the introduction of fine-needle biopsy of the thyroid gland with subsequent evaluation of cytological material using the Bethesda system. One category of this classification traditionally remains a gray area of diagnosis. The detection of a follicular tumor in the cytological material (category IV according to Bethesda) does not allow one to reliably classify the neoplasia as benign or malignant and requires surgical intervention. The traditional informative and widely used method for diagnosing thyroid tumors is ultrasound. However, the sensitivity and specificity of the method varies over a wide range. This review analyzes the literature on the possibilities of ultrasound diagnostics in assessing the malignant potential of follicular tumors of the thyroid gland.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82221770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological assistance to patients with thyroid cancer 对甲状腺癌患者的心理援助
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-59-64
G. Tkachenko, T. Grushina, Y. Alymov, S. Podvyaznikov
Introduction. Thyroid cancer has a favorable prognosis but in long term patients are observed to be in psychological distress manifesting through elevated anxiety and depression which disrupt social adaptation. Studies have shown that 2–4 years after diagnosis and treatment of this malignant tumor, the majority of patients report dissatisfaction with family relationships and difficulties in performing everyday activities. These data demonstrate the necessity of rehabilitation aimed at patient adaptation to everyday life after therapy completion. Psychological help is an important aspect of rehabilitation.Aim. To evaluate the effectiveness of psychological help in patients with thyroid cancer.Materials and methods. The study included 42 women with thyroid cancer, stages I–III, Т1–3N0–1М0. Mean patient age was 44.5 ± 1.1 years. The patients were randomly divided into 2 groups matched by age, disease stage and type of surgical intervention: treatment and control groups. The treatment group (n = 24) included patients who underwent psychological training in the postoperative period, the control group (n = 18) included patients who did not receive psychological help. Mental state was evaluated using the Hospital Anxiety and Depression Scale (HADS). The patients’ mental state was evaluated dynamically: 1st testing was performed after surgery, 2nd testing 12 months after surgery. Psychological training was performed in the postoperative period and included 5 individual classes teaching self-regulation skills.Results. After the surgery, HADS scale showed insignificant increase in anxiety in both groups. Analysis of repeat testing showed decreased anxiety levels in patients in the treatment group from 7.7 ± 0.2 to 6.3 ± 0.2, i. e. to normal level. In the control group, anxiety significantly increased from 7.8 ± 0.2 to 9.2 ± 0.2 (Student’s t-test = 5.17; p = 0.000168). Additionally, 12 months after surgical treatment statistically significant differences in anxiety levels between groups were observed: 6.3 ± 0.2 and 9.0 ± 0.2, respectively (Student’s t-test = 9.55; р <0.05). Primary examination showed subthreshold depression in patients of both groups: 7.9 ± 0.1 and 8.1 ± 0.2, respectively. No statistically significant differences between the groups were observed (Student’s t-test = 0.89; р >0.05). Repeat examination showed decreased depression level (in treatment group from 7.9 ± 0.1 to 7.4 ± 0.2, in the control group from 8.1 ± 0.2 to 7.7 ± 0.1), however it remained in the range of mean values. No statistically significant differences between the groups were observed (Student’s t-test = 1.34; р >0.05).Conclusion. Psychological training using self-regulation techniques performed in the early postoperative period normalizes anxiety level and prevents its elevation in long term in patients with thyroid cancer.
介绍。甲状腺癌预后良好,但长期存在焦虑、抑郁等心理困扰,影响社会适应。研究表明,在诊断和治疗这种恶性肿瘤2-4年后,大多数患者报告对家庭关系不满意,日常活动困难。这些数据证明了康复治疗的必要性,目的是使患者在治疗完成后适应日常生活。心理帮助是康复的一个重要方面。评价心理帮助在甲状腺癌患者中的效果。材料和方法。该研究包括42名患有甲状腺癌的女性,I-III期,Т1-3N0-1М0。患者平均年龄44.5±1.1岁。将患者按年龄、疾病分期、手术干预方式随机分为治疗组和对照组。治疗组(n = 24)包括术后接受心理训练的患者,对照组(n = 18)包括未接受心理帮助的患者。采用医院焦虑抑郁量表(HADS)评价患者的精神状态。动态评估患者的精神状态:第一次在术后进行,第二次在术后12个月进行。术后进行心理训练,包括5个自我调节技巧个课。术后HADS量表显示两组患者焦虑水平均无明显升高。重复测试分析显示,治疗组患者焦虑水平由7.7±0.2降至6.3±0.2,即恢复正常水平。在对照组中,焦虑从7.8±0.2显著增加到9.2±0.2(学生t检验= 5.17;P = 0.000168)。此外,术后12个月组间焦虑水平差异有统计学意义:分别为6.3±0.2和9.0±0.2(学生t检验= 9.55;р0.05)。重复检查显示抑郁水平下降(治疗组从7.9±0.1降至7.4±0.2,对照组从8.1±0.2降至7.7±0.1),但仍保持在平均值范围内。各组间差异无统计学意义(学生t检验= 1.34;р.Conclusion > 0.05)。术后早期采用自我调节技术进行心理训练可使甲状腺癌患者的焦虑水平正常化,并防止其长期升高。
{"title":"Psychological assistance to patients with thyroid cancer","authors":"G. Tkachenko, T. Grushina, Y. Alymov, S. Podvyaznikov","doi":"10.17650/2222-1468-2023-13-1-59-64","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-59-64","url":null,"abstract":"Introduction. Thyroid cancer has a favorable prognosis but in long term patients are observed to be in psychological distress manifesting through elevated anxiety and depression which disrupt social adaptation. Studies have shown that 2–4 years after diagnosis and treatment of this malignant tumor, the majority of patients report dissatisfaction with family relationships and difficulties in performing everyday activities. These data demonstrate the necessity of rehabilitation aimed at patient adaptation to everyday life after therapy completion. Psychological help is an important aspect of rehabilitation.Aim. To evaluate the effectiveness of psychological help in patients with thyroid cancer.Materials and methods. The study included 42 women with thyroid cancer, stages I–III, Т1–3N0–1М0. Mean patient age was 44.5 ± 1.1 years. The patients were randomly divided into 2 groups matched by age, disease stage and type of surgical intervention: treatment and control groups. The treatment group (n = 24) included patients who underwent psychological training in the postoperative period, the control group (n = 18) included patients who did not receive psychological help. Mental state was evaluated using the Hospital Anxiety and Depression Scale (HADS). The patients’ mental state was evaluated dynamically: 1st testing was performed after surgery, 2nd testing 12 months after surgery. Psychological training was performed in the postoperative period and included 5 individual classes teaching self-regulation skills.Results. After the surgery, HADS scale showed insignificant increase in anxiety in both groups. Analysis of repeat testing showed decreased anxiety levels in patients in the treatment group from 7.7 ± 0.2 to 6.3 ± 0.2, i. e. to normal level. In the control group, anxiety significantly increased from 7.8 ± 0.2 to 9.2 ± 0.2 (Student’s t-test = 5.17; p = 0.000168). Additionally, 12 months after surgical treatment statistically significant differences in anxiety levels between groups were observed: 6.3 ± 0.2 and 9.0 ± 0.2, respectively (Student’s t-test = 9.55; р <0.05). Primary examination showed subthreshold depression in patients of both groups: 7.9 ± 0.1 and 8.1 ± 0.2, respectively. No statistically significant differences between the groups were observed (Student’s t-test = 0.89; р >0.05). Repeat examination showed decreased depression level (in treatment group from 7.9 ± 0.1 to 7.4 ± 0.2, in the control group from 8.1 ± 0.2 to 7.7 ± 0.1), however it remained in the range of mean values. No statistically significant differences between the groups were observed (Student’s t-test = 1.34; р >0.05).Conclusion. Psychological training using self-regulation techniques performed in the early postoperative period normalizes anxiety level and prevents its elevation in long term in patients with thyroid cancer.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85612810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician 放射性碘残留消融治疗分化型甲状腺癌的随访:核医学医师的观点
Pub Date : 2023-06-01 DOI: 10.17650/2222-1468-2023-13-1-91-101
A. Shurinov, E. Borodavina
Timeliness of accurate dynamic observation and a clear understanding of the treatment response guarantees health of patients with differentiated thyroid cancer. Multidimensional approach to evaluation of thyroid-stimulating hormone, tumor markers, ultrasound picture, as well as results of molecular imaging with radioactive iodine is clearly defined in international clinical guidelines. At the A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center for more than 15 years tactics of control exam 6 months after radioactive iodine ablation has been implemented. The aim of the current article is to consider the sequence of diagnostic search for different responses to treatment of differentiated thyroid cancer.
准确动态观察的及时性和对治疗反应的清晰认识是分化型甲状腺癌患者健康的保障。国际临床指南对促甲状腺激素、肿瘤标志物、超声图像以及放射性碘分子显像结果的多维评价方法有明确的定义。在国家医学研究放射中心下属的A.F. Tsyb医学放射研究中心,实施放射性碘消融后6个月的控制检查策略已超过15年。本文的目的是考虑分化型甲状腺癌治疗的不同反应的诊断搜索顺序。
{"title":"Follow-up after radioiodine remnant ablation in differentiated thyroid cancer: the view of nuclear medicine physician","authors":"A. Shurinov, E. Borodavina","doi":"10.17650/2222-1468-2023-13-1-91-101","DOIUrl":"https://doi.org/10.17650/2222-1468-2023-13-1-91-101","url":null,"abstract":"Timeliness of accurate dynamic observation and a clear understanding of the treatment response guarantees health of patients with differentiated thyroid cancer. Multidimensional approach to evaluation of thyroid-stimulating hormone, tumor markers, ultrasound picture, as well as results of molecular imaging with radioactive iodine is clearly defined in international clinical guidelines. At the A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center for more than 15 years tactics of control exam 6 months after radioactive iodine ablation has been implemented. The aim of the current article is to consider the sequence of diagnostic search for different responses to treatment of differentiated thyroid cancer.","PeriodicalId":12937,"journal":{"name":"Head and neck tumors (HNT)","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73108048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Head and neck tumors (HNT)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1